The microscopic advances that are opening big opportunities in cell biology
Blog from Nature Careers by Nic Fleming – A proliferation of imaging techniques spells good news for careers.
Blog from Nature Careers by Nic Fleming – A proliferation of imaging techniques spells good news for careers.
A new class of CRISPR-based tools efficiently corrects point mutations in cell lines, animal models and perhaps the clinic. Read this blog from the Nature Careers website to find out more.
GV-971, aka oligomannate, receives conditional approval in China for the treatment of mild to moderate Alzheimer’s disease.
A multi-institutional group, including members of the Tau Consortium, unveiled a stem cell tool kit for scientists studying primary tauopathies.
Genetically encoded voltage indicators change colour in real time when neurons transmit electrical information, offering unprecedented insight into neural activity.
The human brain follows a typical ageing trajectory, but diseased brains are further along, according to a paper in the September 24 Nature Neuroscience.
First blog from James Watson sharing his plans and ideas as he embarks on his 1st year of a PhD at the University of Liverpool, researching variations in dementia care pathways and the health and economic impact.
Professor Carla Shatz’s research aims to understand how early developing brain circuits are transformed into adult connections during critical periods of development. This talk given by Professor Shatz for the UK Dementia Research Institute on the 6th September at UCL.
Certain mutations in TREM2 strongly increase risk for late-onset Alzheimer’s. Could tweaking the function of this microglial receptor help people with the disease?
New blog from Anna Volkmer – An international collaboration: Spreading the word on speech and language therapy approaches to managing primary progressive aphasia.
As microglia become more central to Alzheimer’s research, researchers are seeking better model systems to study their in vivo behavior – can chimeric mice provide a solution?
Physical activity not only benefits the heart and the body, it may also shield the brain from the damaging effects of Aβ says study published in JAMA Neurology (July 16)
Get all the support you need sent straight to your inbox. Research news, oppertunities, blogs, podcasts, jobs, events, funding calls and much more – every friday!